Paychex, Inc. · PAYX · FY2025 Q1 · Calendar Q4 2024
Paychex maintains FY2025 outlook as AI products expand
The quarter supports a constructive but qualified view: resilient SMB hiring demand, product expansion and disciplined costs can support growth, while ERTC effects, pricing pressure, insurance costs and interest-rate sensitivity constrain the trajectory.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about PAYX FY2025 Q1
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior analysis, Paychex introduced or emphasized Flex Engage, Perks and Recruiting Copilot, including availability of Recruiting Copilot to non-Paychex payroll customers. Management also highlighted a payroll-funding ecosystem and continued go-to-market investment while keeping the full-year outlook intact.
Guidance delta
Full-year FY2025 guidance was maintained; interest-rate assumptions were revised within the outlook.
Key takeaways
- Management described modest reported revenue growth despite ERTC and processing-day headwinds.
- Operating margin expanded and EPS increased, supported by expense discipline and product mix.
- Flex Engage, Perks and Recruiting Copilot broaden Paychex’s AI-focused product strategy.
- PEO and insurance solutions delivered double-digit growth, while insurance costs remained a headwind.
- The quarter adds product and go-to-market execution evidence, but pricing, hiring and macro risks remain.
Management priorities
- Scale Flex Engage and Perks across more SMB customers
- Expand Recruiting Copilot to non-Paychex payroll customers
- Develop Paychex Promise and fintech partnerships
- Hire and train go-to-market teams for selling season
- Evaluate acquisitions that complement the existing product suite
Follow PAYX with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 24, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Cantor Fitzgerald | Underweight | Underweight | Maintain | Sep 28, 2026 |
| Baird | Neutral | Neutral | Maintain | Sep 28, 2026 |
| UBS | Neutral | Neutral | Maintain | Sep 24, 2026 |
| Stifel | Hold | Hold | Maintain | Sep 24, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Sep 24, 2026 |
| JP Morgan | Neutral | Underweight | Upgrade | Sep 24, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Sep 24, 2026 |
| Wolfe Research | Peer Perform | Underperform | Upgrade | Sep 16, 2026 |
| TD Cowen | Hold | Hold | Maintain | Sep 11, 2026 |
| Wells Fargo | Underweight | Underweight | Maintain | Sep 9, 2026 |
| Jefferies | Hold | Hold | Maintain | Aug 13, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 30, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jun 30, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Mar 31, 2025 |
| B of A Securities | Underperform | Underperform | Maintain | Jun 27, 2024 |
| Wedbush | Neutral | Neutral | Maintain | Apr 3, 2024 |
| Evercore ISI Group | In Line | In Line | Maintain | Mar 26, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Sep 29, 2022 |
| Cowen & Co. | Outperform | Outperform | Maintain | Sep 29, 2022 |
| Deutsche Bank | Hold | Hold | Maintain | Jun 30, 2022 |
| Goldman Sachs | Sell | Sell | Maintain | Apr 7, 2021 |
| Argus Research | Buy | Buy | Maintain | Apr 7, 2021 |
| Bank of America | Neutral | Underperform | Upgrade | Jan 8, 2019 |
| Stifel Nicolaus | Hold | Hold | Maintain | Oct 3, 2018 |
| Guggenheim | Neutral | Neutral | Maintain | Aug 21, 2018 |
| Argus | Buy | Hold | Upgrade | May 5, 2018 |
| William Blair | Market Perform | Outperform | Downgrade | Jul 21, 2017 |
| Bernstein | Perform | Market Perform | Maintain | Jan 11, 2017 |
| Compass Point | Sell | Sell | Maintain | Apr 15, 2016 |
| Sterne Agee CRT | Neutral | Neutral | Maintain | Dec 17, 2015 |
| First Analysis | Equal Weight | Overweight | Downgrade | Sep 26, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $118.04. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Robert W. Baird | Mark Marcon | $110 | $101.37 | -6.8% | Sep 28, 2026 |
| Stifel Nicolaus | Analyst unavailable | $112 | $104.49 | -5.1% | Sep 24, 2026 |
| BMO Capital | Daniel Jester | $113 | $104.49 | -4.3% | Sep 24, 2026 |
| Wells Fargo | Jason Kupferberg | $111 | $116.93 | -6.0% | Sep 9, 2026 |
| UBS | Kevin McVeigh | $115 | $111.96 | -2.6% | Jul 22, 2026 |
| Cantor Fitzgerald | Ramsey El-Assal | $107 | $112.76 | -9.4% | Jul 20, 2026 |
| Morgan Stanley | Analyst unavailable | $109 | $99.81 | -7.7% | Jun 30, 2026 |
| UBS | Analyst unavailable | $98 | $98.84 | -17.0% | Jun 25, 2026 |
| Stifel Nicolaus | Analyst unavailable | $110 | $100.28 | -6.8% | Jun 17, 2026 |
| Morgan Stanley | James Faucette | $107 | $91.68 | -9.4% | Mar 27, 2026 |
| BMO Capital | Daniel Jester | $103 | $92 | -12.7% | Mar 13, 2026 |
| Cantor Fitzgerald | Ramsey El-Assal | $98 | $106.19 | -17.0% | Jan 26, 2026 |
| Morgan Stanley | Analyst unavailable | $123 | $112.28 | +4.2% | Dec 22, 2025 |
| Jefferies | Analyst unavailable | $110 | $112.28 | -6.8% | Dec 19, 2025 |
| Stifel Nicolaus | David Grossman | $126 | $115.22 | +6.7% | Dec 17, 2025 |
| BMO Capital | Analyst unavailable | $121 | $112.45 | +2.5% | Dec 9, 2025 |
| Wells Fargo | Analyst unavailable | $116 | $112.45 | -1.7% | Dec 9, 2025 |
| Jefferies | Analyst unavailable | $118 | $112.06 | -0.0% | Dec 7, 2025 |
| RBC Capital | Ashish Sabadra | $125 | $113.31 | +5.9% | Dec 5, 2025 |
| Wells Fargo | Analyst unavailable | $128 | $127.54 | +8.4% | Oct 21, 2025 |
| Stephens | Charles Nabhan | $135 | $124.37 | +14.4% | Oct 6, 2025 |
| Morgan Stanley | Analyst unavailable | $132 | $126.76 | +11.8% | Oct 1, 2025 |
| BMO Capital | Analyst unavailable | $140 | $126.76 | +18.6% | Oct 1, 2025 |
| Jefferies | Analyst unavailable | $130 | $126.76 | +10.1% | Sep 30, 2025 |
| UBS | Kevin McVeigh | $140 | $131.62 | +18.6% | Sep 16, 2025 |
| Jefferies | Analyst unavailable | $140 | $137.94 | +18.6% | Jun 26, 2025 |
| RBC Capital | Ashish Sabadra | $165 | $150.62 | +39.8% | Jun 24, 2025 |
| Stifel Nicolaus | Analyst unavailable | $156 | $151.83 | +32.2% | Mar 27, 2025 |
| UBS | Kevin McVeigh | $142 | $141.65 | +20.3% | Oct 2, 2024 |
| Barclays | Ramsey El-Assal | $132 | $133.26 | +11.8% | Sep 22, 2024 |
| Argus Research | John Eade | $135 | $118.91 | +14.4% | Jun 28, 2024 |
| Morgan Stanley | James Faucette | $122 | $117.39 | +3.4% | Jun 27, 2024 |
| Robert W. Baird | Mark Marcon | $124 | $117.66 | +5.0% | Jun 27, 2024 |
| Evercore ISI | David Togut | $130 | $117.39 | +10.1% | Jun 26, 2024 |
| Evercore ISI | David Togut | $116 | $120.21 | -1.7% | Apr 2, 2024 |
| Stifel Nicolaus | David Grossman | $130 | $121.5 | +10.1% | Apr 1, 2024 |
| Morgan Stanley | James Faucette | $125 | $112.72 | +5.9% | Sep 27, 2023 |
| RBC Capital | Ashish Sabadra | $130 | $121.37 | +10.1% | Sep 5, 2023 |
| J.P. Morgan | Analyst unavailable | $119 | $116.01 | +0.8% | Dec 23, 2022 |
| Morgan Stanley | Analyst unavailable | $125 | $116.01 | +5.9% | Dec 23, 2022 |
| Barclays | Analyst unavailable | $115 | $116.01 | -2.6% | Dec 23, 2022 |
| Jefferies | Samad Samana | $120 | $112.18 | +1.7% | Dec 22, 2022 |
| Credit Suisse | Kevin Mcveigh | $140 | $113.87 | +18.6% | Jun 30, 2022 |
| Citigroup | Peter Christiansen | $145 | $136.84 | +22.8% | Apr 11, 2022 |
| Bank of America Securities | Jason Kupferberg | $125 | $124.55 | +5.9% | Mar 16, 2022 |
| Cowen & Co. | Bryan Bergin | $145 | $128.28 | +22.8% | Jan 12, 2022 |
| Barclays | Ramsey El Assal | $140 | $133.45 | +18.6% | Dec 23, 2021 |
| Credit Suisse | Kevin Mcveigh | $165 | $133.45 | +39.8% | Dec 23, 2021 |
| Evercore ISI | David Togut | $118 | $133.45 | -0.0% | Dec 23, 2021 |
| MoffettNathanson | Eugene Simuni | $145 | $133.45 | +22.8% | Dec 23, 2021 |
| Stifel Nicolaus | David Grossman | $140 | $132.62 | +18.6% | Dec 22, 2021 |
| BMO Capital | Jeffrey Silber | $118 | $113.86 | -0.0% | Oct 1, 2021 |
| Argus Research | David Coleman | $118 | $105.1 | -0.0% | Jun 28, 2021 |
Track every rating change on PAYX the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationFounded in 1971 and headquartered in Rochester, New York, Paychex, Inc. delivers comprehensive human capital management (HCM) solutions. The company primarily serves small to medium-sized enterprises (SMEs) across the United States, Europe, and India, addressing their needs in human resources, payroll administration, employee benefits, and insurance. Its diverse service portfolio includes: Payroll Management: Encompassing core payroll processing, payroll tax administration, employee payment facilitation, and ensuring compliance with regulations like new-hire reporting and garnishment processing. Human Resources Solutions: Providing support for employer compliance, HR and employee benefits administration, risk management outsourcing, and even the availability of professionally trained on-site HR representatives.…
Historical context
All PAYX earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| FIX Comfort Systems USA, Inc. | FY2026 Q3 · Calendar Q4 2026 | +8.2% | -8.5% | Comfort Systems USA: Strong Growth, Record Backlog, Margin Watchpoints |
| BE Bloom Energy Corporation | FY2026 Q3 · Calendar Q4 2026 | +36.0% | -8.7% | Bloom Energy Raises Outlook as AI Power Demand Drives Expansion |
| SNA Snap-on Incorporated | FY2026 Q3 · Calendar Q4 2026 | -5.9% | -3.4% | Snap-on: C&I strength offsets organic sales pressure in Q3 |
| HON Honeywell International Inc. | FY2026 Q3 · Calendar Q4 2026 | +4.6% | +1.7% | Honeywell Raises 2026 Outlook as Backlog and Forge Support Growth |
| LMT Lockheed Martin Corporation | FY2026 Q3 · Calendar Q4 2026 | +6.0% | +7.0% | Lockheed Martin: backlog and guidance rise, with execution risks |
| NSC Norfolk Southern Corporation | FY2026 Q3 · Calendar Q4 2026 | +4.6% | +3.1% | Norfolk Southern posts strong Q3 as capex outlook rises |
Latest beats and misses
Who reports nextBeat on EPS
- FCNCAFY2026 Q3 · October 23, 2026+19.9% EPS+8.2% move
- FCNCNFY2026 Q3 · October 23, 2026+19.9% EPS+0.2% move
- FCNCOFY2026 Q3 · October 23, 2026+19.9% EPS+1.0% move
- FCNCPFY2026 Q3 · October 23, 2026+19.9% EPS+1.0% move
- RDYFY2027 Q2 · October 23, 2026+24.0% EPS-0.2% move
- SLBFY2026 Q3 · October 23, 2026+3.7% EPS+7.1% move
Missed on EPS
- INFYFY2027 Q2 · October 23, 2026-4.8% EPS-6.6% move
- BBDFY2026 Q3 · October 22, 2026-7.7% EPS+3.0% move
- SNAFY2026 Q3 · October 22, 2026-5.9% EPS-3.4% move
- SPOTFY2026 Q3 · October 22, 2026-11.6% EPS+11.1% move
- VRSNFY2026 Q3 · October 22, 2026-2.0% EPS-0.9% move
- HBANMFY2026 Q3 · October 22, 2026-5.3% EPS+0.5% move
Get the PAYX recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-10-17T05:10:49.140638+00:00
- Polygon adjusted daily market bars · 2026-10-24T16:40:42.289923+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-24T16:40:42.287090+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-24. For educational purposes only; not investment advice.